EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02

Ruohui Zheng iD, Edward J Fuchs, Sridhar Nimmagadda iD, Lisa C Rohan, Lin Wang, Lynn N Bertagnolli iD, Sandra Massih iD, Brian S Caffo iD, Craig W Hendrix iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf286 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Ruohui Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Anti-HIV Agents, Colon, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Men who have sex with men are at high risk of human immunodeficiency virus (HIV) acquisition through unprotected receptive anal intercourse (RAI). Behaviorally congruent HIV preexposure prophylaxis (PrEP) has long been advocated by individuals who find adherence challenging or prefer minimizing systemic drug concentrations. We developed an event-driven, behaviorally congruent rectal tenofovir douche as a PrEP option for RAI and demonstrated product safety/acceptability in a previous clinical study. Here, our goal was to compare colorectal distribution of an HIV surrogate and tenofovir douche when the tenofovir douche preceded or followed simulated RAI (sRAI).

Methods

Five participants completed 2 paired study visits. At visit one, participants received an 111indium-diethylenetriaminepentaacetic acid-labelled tenofovir douche prior to sRAI using 99mTc-sulfur colloid in autologous semen as HIV surrogate. At visit two, the radiolabeled tenofovir douche was administered following radiolabeled sRAI. Colorectal distribution of both douche and HIV surrogate radioisotopes were assessed using single-photon emission computed tomography/transmission computed tomography. Systemic permeability was assessed by plasma TFV concentrations.

Results

Colorectal distribution of the douche was not different between sequences. Conversely, the majority of HIV surrogate was within the rectosigmoid when the douche was administered prior to sRAI, but the distribution extended into descending colon when the douche was administered following sRAI. Regardless of sequence, an early plasma TFV peak 20 minutes after dosing was observed.

Conclusions

Douching following RAI may increase HIV distribution in the colon with uncertain impact on HIV acquisition risk. The early plasma TFV suggests even more rapid time to protection than reported in prior studies. Clinical Trials Registration NCT04195776.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsColonHIV InfectionsPre-Exposure ProphylaxisRectumTenofovirAdultHumansMaleMiddle AgedAdministration, RectalHomosexuality, MaleSexual Behavior

Stichwörter der Autor:innen

HIVSPECT/CT imaginganal sexpreexposure prophylaxisrectal microbicide

Substanzen

Anti-HIV AgentsTenofovir

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
  • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Ruohui Zheng, Sridhar Nimmagadda, Lynn N Bertagnolli, Sandra Massih, Brian S Caffo, Craig W Hendrix

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • Division of AIDS
  • Clinical Pharmacology Training Program
  • Johns Hopkins University School of Medicine
  • National Institue of General Medical Sciences

Zitieren

APA

Zheng, R., Fuchs, E. J., Nimmagadda, S., Rohan, L. C., Wang, L., Bertagnolli, L. N., Massih, S., Caffo, B. S., & Hendrix, C. W. (2025). Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf286

Vancouver

Zheng R, Fuchs EJ, Nimmagadda S, Rohan LC, Wang L, Bertagnolli LN, et al. Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf286

BibTeX
@article{Zheng2025,
  author = {Zheng, Ruohui and Fuchs, Edward J and Nimmagadda, Sridhar and Rohan, Lisa C and Wang, Lin and Bertagnolli, Lynn N and Massih, Sandra and Caffo, Brian S and Hendrix, Craig W},
  title = {Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf286}
}
Kostenlos starten →